538 related articles for article (PubMed ID: 14601091)
21. Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones.
Havrilesky LJ; McMahon CP; Lobenhofer EK; Whitaker R; Marks JR; Berchuck A
J Soc Gynecol Investig; 2001; 8(2):104-13. PubMed ID: 11336882
[TBL] [Abstract][Full Text] [Related]
22. Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific co-activator.
Hudelist G; Czerwenka K; Kubista E; Marton E; Pischinger K; Singer CF
Breast Cancer Res Treat; 2003 Mar; 78(2):193-204. PubMed ID: 12725419
[TBL] [Abstract][Full Text] [Related]
23. Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR).
Mylonas I; Jeschke U; Shabani N; Kuhn C; Kriegel S; Kupka MS; Friese K
Anticancer Res; 2005; 25(3A):1679-86. PubMed ID: 16033082
[TBL] [Abstract][Full Text] [Related]
24. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription.
Smith CL; Oñate SA; Tsai MJ; O'Malley BW
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):8884-8. PubMed ID: 8799122
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical analysis of steroid receptors, proliferation markers, apoptosis related molecules, and gelatinases in non-neoplastic and neoplastic endometrium.
Amalinei C; Cianga C; Balan R; Cianga P; Giusca S; Caruntu ID
Ann Anat; 2011 Feb; 193(1):43-55. PubMed ID: 21145716
[TBL] [Abstract][Full Text] [Related]
26. The steroid receptor co-activator-1 (SRC-1) potentiates TGF-beta/Smad signaling: role of p300/CBP.
Dennler S; Pendaries V; Tacheau C; Costas MA; Mauviel A; Verrecchia F
Oncogene; 2005 Mar; 24(11):1936-45. PubMed ID: 15688032
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor-alpha suppresses the expression of steroid receptor coactivator-1 and -2: a possible mechanism contributing to changes in steroid hormone responsiveness.
Leite RS; Brown AG; Strauss JF
FASEB J; 2004 Sep; 18(12):1418-20. PubMed ID: 15231721
[TBL] [Abstract][Full Text] [Related]
28. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action.
Shibata H; Spencer TE; Oñate SA; Jenster G; Tsai SY; Tsai MJ; O'Malley BW
Recent Prog Horm Res; 1997; 52():141-64; discussion 164-5. PubMed ID: 9238851
[TBL] [Abstract][Full Text] [Related]
29. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
[TBL] [Abstract][Full Text] [Related]
30. Involvement of nuclear receptor coactivator SRC-1 in estrogen-dependent cell growth of MCF-7 cells.
Tai H; Kubota N; Kato S
Biochem Biophys Res Commun; 2000 Jan; 267(1):311-6. PubMed ID: 10623616
[TBL] [Abstract][Full Text] [Related]
31. Ski-interacting protein, a bifunctional nuclear receptor coregulator that interacts with N-CoR/SMRT and p300.
Leong GM; Subramaniam N; Issa LL; Barry JB; Kino T; Driggers PH; Hayman MJ; Eisman JA; Gardiner EM
Biochem Biophys Res Commun; 2004 Mar; 315(4):1070-6. PubMed ID: 14985122
[TBL] [Abstract][Full Text] [Related]
32. Coregulatory protein-orphan nuclear receptor interactions in the human adrenal cortex.
Kelly SN; McKenna TJ; Young LS
J Endocrinol; 2005 Jul; 186(1):33-42. PubMed ID: 16002533
[TBL] [Abstract][Full Text] [Related]
33. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
34. Class I histone deacetylase expression in the human cyclic endometrium and endometrial adenocarcinomas.
Krusche CA; Vloet AJ; Classen-Linke I; von Rango U; Beier HM; Alfer J
Hum Reprod; 2007 Nov; 22(11):2956-66. PubMed ID: 17728353
[TBL] [Abstract][Full Text] [Related]
35. Fatty acid synthase expression in endometrial carcinoma: correlation with cell proliferation and hormone receptors.
Pizer ES; Lax SF; Kuhajda FP; Pasternack GR; Kurman RJ
Cancer; 1998 Aug; 83(3):528-37. PubMed ID: 9690546
[TBL] [Abstract][Full Text] [Related]
36. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
[TBL] [Abstract][Full Text] [Related]
37. [Immunohistochemical study of the expression of receptors to steroid hormones in endometrial hyperplastic processes].
Lysenko ON; Ashkhab MKh; Strizhova NV; Babichenko II
Arkh Patol; 2004; 66(2):7-10. PubMed ID: 15154374
[TBL] [Abstract][Full Text] [Related]
38. [Effects of mifepristone on expression of estrogen receptor and progesterone receptor in cultured human eutopic and ectopic endometria].
Jiang J; Wu R; Wang Z
Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):218-21. PubMed ID: 11783365
[TBL] [Abstract][Full Text] [Related]
39. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma.
Hamid AA; Mandai M; Konishi I; Nanbu K; Tsuruta Y; Kusakari T; Kariya M; Kita M; Fujii S
Cancer; 2002 Feb; 94(4):997-1005. PubMed ID: 11920468
[TBL] [Abstract][Full Text] [Related]
40. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.
Dutertre M; Smith CL
Mol Endocrinol; 2003 Jul; 17(7):1296-314. PubMed ID: 12714702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]